Cybeats Technologies Corp. (TSE:CYBT) has released an update.
Cybeats Technologies Corp. has renewed a significant contract with a leading global Medical Device Manufacturer, in line with FDA guidelines emphasizing the importance of Software Bills of Materials for medical device cybersecurity. The deal showcases Cybeats’ SBOM Studio’s pivotal role in helping the healthcare industry meet new regulatory requirements and maintain software supply chain security. The company’s continued success is exemplified by its 100% client retention rate and participation in key industry events, such as the upcoming H-ISAC Spring Americas Summit.
For further insights into TSE:CYBT stock, check out TipRanks’ Stock Analysis page.
